Capnography During ERCP

Capnography as an Adjunct to Standard Monitoring During Midazolam and Propofol Sedation for ERCP

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01072474

Acronym

EndoBreath

Enrollment

242

Registered

2010-02-22

Start date

2010-02-28

Completion date

2012-03-31

Last updated

2012-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia, Complications

Keywords

Safety, Sedation, Gastrointestinal endoscopy, Colonoscopy

Brief summary

In the study the value of capnography for avoiding complications during sedation for ERCP is evaluated.

Detailed description

In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Interventions

PROCEDURECapnography

Capnographic monitoring

PROCEDUREStandard monitoring

Standard monitoring

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age\>=18 * Scheduled for colonoscopy with midazolam and propofol sedation

Exclusion criteria

* No informed consent * ASA V * Pregnancy * Prexisting hypotension, bradycardia or hypoxemia

Design outcomes

Primary

Measure	Time frame
Hypoxemia	From the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h

Secondary

Measure	Time frame
Further complications	From the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026